Everest Group Ltd is a Bermuda-based reinsurance and insurance organization. It operates in the Reinsurance and Insurance business. It is a financial services institution focused on diversifying its portfolio and geographic presence. Through direct and indirect subsidiaries operating in the U.S. and internationally. The Insurance operation writes property and casualty insurance directly and through brokers, surplus lines brokers, and general agents within the U.S., Bermuda, Canada, Europe, and South America. The Company conducts business through two reportable segments, Reinsurance and Insurance.
Last trade$426.83
Day change-$6.17 (-1.42%)
Day range$425.68 – $431.82
Volume252,745
Market cap$16.04B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$16.04B
Price / earnings
8.41×
Price / book
1.04×
Price / sales
0.96×
EV / sales
1.11×
EV / EBITDA
7.75×
Profitability
Earnings per share
$51.51
Return on assets
3.07%
Return on equity
12.37%
Dividend yield
2.02%
Liquidity and leverage
Debt / equity
0.23×
Current ratio
1.12×
Quick ratio
1.12×
Cash ratio
0.15×
Cash flow
Price / cash flow
8.02×
Price / free cash flow
8.02×
Free cash flow
$2B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for EG, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$3.96B
$4.07B
$4.42B
$4.32B
$4.49B
$4.26B
$4.64B
$4.29B
Cost of revenue
$2.17B
$2.22B
$2.66B
$2.84B
$2.47B
$2.89B
$4.17B
$2.58B
Gross profit
$1.79B
$1.85B
$1.77B
$1.48B
$2.02B
$1.37B
$463M
$1.7B
Selling, general and administrative
$1.04B
$1.04B
$1.15B
$1.15B
$1.13B
$1.06B
$1.15B
$1.06B
Research and development
—
—
—
—
—
—
—
—
Total operating expenses
$3.24B
$3.3B
$3.83B
$4.01B
$3.64B
$3.98B
$5.35B
$3.67B
Operating income
$719M
$772M
$592M
$307M
$854M
$287M
-$709M
$614M
Interest expense
-$36M
-$36M
-$37M
-$38M
-$38M
-$38M
-$37M
-$38M
Income before taxes
$683M
$736M
$555M
$269M
$815M
$248M
-$748M
$577M
Income taxes
$124M
$83M
$109M
$14M
$135M
$39M
-$155M
$68M
Net income
$559M
$653M
$446M
$255M
$680M
$209M
-$593M
$509M
Net income attributable to common shareholders
$552M
$645M
$459M
$252M
$672M
$208M
-$570M
$503M
EBITDA
$719M
$772M
$592M
$307M
$854M
$287M
-$709M
$614M
Basic earnings per share
$14.22
$16.21
$10.70
$6.09
$16.10
$4.90
-$12.81
$11.80
Diluted earnings per share
$14.22
$16.21
$10.70
$6.09
$16.10
$4.90
-$12.81
$11.80
Recent news
Company coverage with links to the original publishers.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure, inadequate pricing, and insufficient reserves. Chemours and Fluence Energy also face similar securities fraud allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
Law firm Bronstein, Gewirtz & Grossman, LLC has announced class action lawsuits against three companies for alleged securities fraud violations. Fluence Energy is accused of making false statements about its ability to deliver backlog and meet fiscal 2026 guidance due to incomplete manufacturing facilities and unresolved production problems. Similar class actions have been filed against Everest Group and Chemours Company, with lead plaintiff deadlines in late 2026.
Three class action lawsuits have been filed against Chemours Company, Everest Group, Ltd., and Fluence Energy, Inc. for alleged securities fraud violations. Chemours is accused of overstating aftermarket demand for Opteon products and providing unreliable financial guidance. Investors in all three companies are encouraged to seek recovery, with lead plaintiff deadlines ranging from November 30, 2026 to December 28, 2026.
Rosen Law Firm is reminding investors who purchased Everest Group common stock between February 8, 2024 and October 27, 2025 of an important December 28, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Everest made materially false statements regarding casualty risk exposure, inadequate pricing, insufficient reserves, and overstated earnings.
Law firm Bronstein Gewirtz & Grossman has filed class action lawsuits against three companies for alleged securities fraud violations. Everest Group is accused of making false statements about casualty risk exposure and inadequate reserve pricing. Arbor Realty Trust and Chemours Company face similar allegations. Investors who purchased securities during specified periods are eligible to seek recovery.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
Declared upcoming dividend$2.00 per share
Declared
Nov 4, 2026
Ex-dividend
Dec 4, 2026
Pay date
Dec 18, 2026
Ex-dividend
Amount / share
Pay date
Type
Sep 9, 2026
$2.00
Sep 25, 2026
recurring
Jun 12, 2026
$2.00
Jun 26, 2026
recurring
Mar 13, 2026
$2.00
Mar 27, 2026
recurring
Nov 26, 2025
$2.00
Dec 12, 2025
recurring
Sep 3, 2025
$2.00
Sep 19, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.